Predicting personalised risk of disability worsening in multiple sclerosis with machine learning
View ORCID ProfileArman Eshaghi, View ORCID ProfilePeter A Wijeratne, View ORCID ProfileNeil P Oxtoby, View ORCID ProfileDouglas L Arnold, View ORCID ProfileLouis Collins, Sridar Narayanan, View ORCID ProfileCharles R. G. Guttmann, View ORCID ProfileAlan J Thompson, View ORCID ProfileDaniel C Alexander, View ORCID ProfileFrederik Barkhof, View ORCID ProfileDeclan Chard, View ORCID ProfileOlga Ciccarelli
doi: https://doi.org/10.1101/2022.02.03.22270364
Arman Eshaghi
1NMR Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, UK WC1B5EH
2Centre for Medical Image Computing (CMIC), Department of Computer Science, University College London, London, UK
Peter A Wijeratne
2Centre for Medical Image Computing (CMIC), Department of Computer Science, University College London, London, UK
Neil P Oxtoby
2Centre for Medical Image Computing (CMIC), Department of Computer Science, University College London, London, UK
Douglas L Arnold
3McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
Louis Collins
3McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
Sridar Narayanan
3McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
Charles R. G. Guttmann
4Center for Neurological Imaging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
Alan J Thompson
1NMR Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, UK WC1B5EH
Daniel C Alexander
2Centre for Medical Image Computing (CMIC), Department of Computer Science, University College London, London, UK
7National Institute for Health Research University College London Hospitals, Biomedical Research Centre, London, UK
Frederik Barkhof
1NMR Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, UK WC1B5EH
6Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, multiple sclerosis Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands
7National Institute for Health Research University College London Hospitals, Biomedical Research Centre, London, UK
Declan Chard
1NMR Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, UK WC1B5EH
7National Institute for Health Research University College London Hospitals, Biomedical Research Centre, London, UK
Olga Ciccarelli
1NMR Unit, Queen Square Multiple Sclerosis Centre, UCL Queen Square Institute of Neurology, Department of Neuroinflammation, Faculty of Brain Sciences, University College London, UK WC1B5EH
7National Institute for Health Research University College London Hospitals, Biomedical Research Centre, London, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The data sets are controlled by pharmaceutical companies. Requests to access data can be forwarded to data controllers listed in our previous publication17. Processed CSV files can be from the corresponding author by any qualified investigator for reproducing the results of this study.
Posted February 03, 2022.
Predicting personalised risk of disability worsening in multiple sclerosis with machine learning
Arman Eshaghi, Peter A Wijeratne, Neil P Oxtoby, Douglas L Arnold, Louis Collins, Sridar Narayanan, Charles R. G. Guttmann, Alan J Thompson, Daniel C Alexander, Frederik Barkhof, Declan Chard, Olga Ciccarelli
medRxiv 2022.02.03.22270364; doi: https://doi.org/10.1101/2022.02.03.22270364
Predicting personalised risk of disability worsening in multiple sclerosis with machine learning
Arman Eshaghi, Peter A Wijeratne, Neil P Oxtoby, Douglas L Arnold, Louis Collins, Sridar Narayanan, Charles R. G. Guttmann, Alan J Thompson, Daniel C Alexander, Frederik Barkhof, Declan Chard, Olga Ciccarelli
medRxiv 2022.02.03.22270364; doi: https://doi.org/10.1101/2022.02.03.22270364
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)